Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen injection for bleeding reduction in total knee arthroplasty
IRCT20190222042803N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of Fibrinogen human in knee osteoarthritis (OA) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Bleeding after surgery. Started Feb 2019; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20190222042803N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190222042803N1.